Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pharmacological and Toxicological Methods|December 27, 2017
Evaluation of the suitability of a Sprague Dawley rat model to assess intravenous iron preparationsKimberley Span, Ebel H E Pieters, Vera Brinks, et al.
Investigational New Drugs|December 15, 2018
The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphateEvelien A W Smits, José A Soetekouw, Ebel H E Pieters, et al.
Pharmaceutical Research|March 10, 2018
The Use of Magnetic Resonance Imaging for Non-Invasive Assessment of Venofer® Biodistribution in RatsKimberley Span, Ebel H E Pieters, Wim E Hennink, et al.
Biomaterials|November 6, 2012
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapyMarina Talelli, Sabrina Oliveira, Cristianne J F Rijcken, et al.
International Journal of Nanomedicine|February 16, 2012
Targeting of a platinum-bound sunitinib analog to renal proximal tubular cellsM E M Dolman, Stefan Harmsen, Ebel H E Pieters, et al.
Molecular Pharmaceutics|July 30, 2013
Inhibition of tumor growth by targeted anti-EGFR/IGF-1R nanobullets depends on efficient blocking of cell survival pathwaysRoy van der Meel, Sabrina Oliveira, Isil Altintas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 14, 2012
A micelle-shedding thermosensitive hydrogel as sustained release formulationAlbert J de Graaf, Inês I Azevedo Próspero dos Santos, Ebel H E Pieters, et al.
Macromolecular Bioscience|October 15, 2011
Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogueM E Emmy M Dolman, Kim M A van Dorenmalen, Ebel H E Pieters, et al.
ACS Nano|April 2, 2015
Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric MicellesYang Shi, Roy van der Meel, Benjamin Theek, et al.
Oncotarget|June 17, 2014
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammationTom Groot Kormelink, Desmond G Powe, Sylvia A Kuijpers, et al.
Pageof 2